• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Propylthiouracil may be equivocal to methimazole for treatment of thyroid storm

bySoroush NedaieandAlex Chan
April 28, 2023
in Emergency, Endocrinology
Reading Time: 2 mins read
Prevalence of hypertension among adolescents varies by race and BMI
Share on FacebookShare on Twitter

1. In this multi-centre cohort study, there were no significant differences in mortality or adverse effects between methimazole and propylthiouracil in the management of thyroid storm.

Evidence Rating Level: 2 (Good)

Thyroid storm is a medical emergency characterized by severe thyrotoxicosis that results in potentially fatal acute end-organ damage and is therefore associated with a high mortality rate of 8-25%. Management of thyroid storm includes thioamides (propylthiouracil, methimazole, or carbimazole), but there is global variation in the recommendations for first-line thioamide therapy. The Premier Healthcare Database was used to identify and evaluate a cohort of 1383 patients admitted to US intensive or intermediate care units with a diagnosis of thyroid storm between January 2016 to December 2020, to compare the efficacy of propylthiouracil and methimazole as treatments. The primary composite outcome of in-hospital death or hospice discharge occurred in 8.5% (95% CI, 6.4%-10.7%) of patients in the propylthiouracil group and 7.4% (95% CI, 4.6%-8.1%)  of patients in the methimazole group. This difference was not statistically significant according to the adjusted risk difference of 0.6% (95% CI, −1.8% to 3.0%, P = .64). Similarly, no differences were found in the outcomes of in-hospital mortality alone, hospice discharge alone, duration of organ support, or total hospitalization costs. There was a small decrease in thioamide-specific costs when using methimazole compared to propylthiouracil (adjusted mean difference, $72 [95% CI, $48 to $97]; P < .001). Despite this, these results suggest that propylthiouracil and methimazole can be used interchangeably in the management of thyroid storm.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Resistance training is associated with lower risk of type 2 diabetes

TikTok’s cortisol face trend meets endocrine reality

Tags: emergency medicineendocrinologythyroid storm
Previous Post

The impact of oral health management on mental health outcomes remains inconclusive

Next Post

Esketamine likely ineffective as an agent for supplemental analgesia during elective cesarean delivery

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Chronic Disease

Resistance training is associated with lower risk of type 2 diabetes

July 2, 2026
Sleep duration inversely related to childhood type 2 diabetes risk makers
Chronic Disease

TikTok’s cortisol face trend meets endocrine reality

September 4, 2026
Contrast-enhanced computed tomography associated with high sensitivity to renal stone detection
Emergency

Renal point-of-care ultrasound may be effective at identifying patients with nephrolithiasis

April 13, 2026
Next Post
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery

Esketamine likely ineffective as an agent for supplemental analgesia during elective cesarean delivery

Eczema more prevalent among older adults than previously thought

ECZTRA 6 Phase 3 Randomized Trial Supports Tralokinumab for Adolescent Moderate-to-Severe Atopic Dermatitis

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

2 Minute Medicine Rewind May 1, 2023

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.